|
KMID : 1141720180060020084
|
|
폐쇄성폐질환
2018 Volume.6 No. 2 p.84 ~ p.87
|
|
|
|
|
Rhee Chin-Kook
Park Yong-Bum
|
|
|
Abstract
|
|
|
|
In the year 2018, Korean Academy of Tuberculosis and Respiratory Diseases (KATRD) has revised chronic obstructive pulmonary disease (COPD) guideline. In the assessment, forced expiratory volume in one second (FEV1) less than 60% of predicted is included as criteria for high risk group. Recommended medication for group “Ga” is short acting beta agonist. For patients with group “Na”, long acting beta agonist (LABA), long acting muscarinic antagonist (LAMA), and also LABA plus LAMA (LABA＋LAMA) combination were equally recommended as first line treatment. For group “Da”, LABA＋LAMA was recommended as first line treatment.
|
|
|
KEYWORD
|
|
|
COPD, Guideline, Treatment
|
|
|
FullTexts / Linksout information
|
|
|
|
|
|
Listed journal information
|
|
|
|